Live-cell single-vRNP imaging identifies viral gene expression signatures that shape influenza infection heterogeneity
Cell Systems · 2026
DOI: 10.1016/j.cels.2025.101489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Systems, 2026. Verfasst von Huib H Rabouw und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hubrecht Institute-KNAW, Oncode Institute, and University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Influenza A virus, Ribonucleoproteins, Influenza, Human, Single Molecule Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KWF Kankerbestrijding, European Research Council, National Institute of Allergy and Infectious Diseases Division of Intramural Research.
Abstract (Originalsprache)
Cell-to-cell heterogeneity in infection outcome is a general feature of most viruses, but the underlying mechanisms are poorly understood. Here, we developed a live-cell single-molecule imaging technology to visualize infection by unmodified influenza A viruses (IAVs) with unprecedented resolution. Using this approach, we generated a detailed kinetic map of IAV infection, which identified viral ribonucleoprotein (vRNP) replication, nuclear export, and virion budding as important sources of heterogeneity. Mechanistically, we show that infection heterogeneity is caused by differential viral gene expression signatures, resulting from widespread transcriptional defects and loss of viral genome segments. For example, loss of NS, but surprisingly not polymerase subunits, severely delays replication onset, and loss of M and NS, but not HA, underlies vRNP nuclear export defects. In summary, our work identifies the origin and consequences of infection heterogeneity and provides a broadly applicable technology that allows high-resolution phenotyping of unmodified IAVs and other negative-strand RNA viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubrecht Institute-KNAW, Oncode Institute, and University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands.
- Department of Viroscience, Erasmus University Medical Center, 3015 GD Rotterdam, the Netherlands.
- Hubrecht Institute-KNAW, Oncode Institute, and University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands; Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center,…
- Hubrecht Institute-KNAW, Oncode Institute, and University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands; Department of Bionanoscience, Kavli Institute of Nanoscience Delft, Delft University of Technology; 262…
Förderung
- KWF Kankerbestrijding
- European Research Council
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- Oncode Institute
- European Commission
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Rabouw, H. H., Schokolowski, J., Müller, M., Baars, M. J. D., Dost, A. F. M., Bestebroer, T. M., Püschel, J., Clevers, H., Fouchier, R. A. M., & Tanenbaum, M. E. (2026). Live-cell single-vRNP imaging identifies viral gene expression signatures that shape influenza infection heterogeneity. Cell Systems. https://doi.org/10.1016/j.cels.2025.101489
Vancouver
Rabouw HH, Schokolowski J, Müller M, Baars MJD, Dost AFM, Bestebroer TM, et al. Live-cell single-vRNP imaging identifies viral gene expression signatures that shape influenza infection heterogeneity. Cell Systems. 2026. doi:10.1016/j.cels.2025.101489
BibTeX
@article{Rabouw2026,
author = {Rabouw, Huib H and Schokolowski, Janin and Müller, Micha and Baars, Matthijs J D and Dost, Antonella F M and Bestebroer, Theo M and Püschel, Jakob and Clevers, Hans and Fouchier, Ron A M and Tanenbaum, Marvin E},
title = {Live-cell single-vRNP imaging identifies viral gene expression signatures that shape influenza infection heterogeneity},
journal = {Cell Systems},
year = {2026},
doi = {10.1016/j.cels.2025.101489}
}
EUVIMED